TrialJAMA oncology2018

Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial.

Janet E Murphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.